Search ARM

Stimuliver was founded in Denmark and is a spinout from the University of Edinburgh. The company is developing a scalable, safe and effective treatment for liver diseases using liver tissue implants developed from pluripotent stem cells. By utilizing pluripotent stem cells as a source of tissue, the technology Stimuliver has developed is scalable and not dependent on donor organ availability. This may in the future provide a treatment which is available without waiting time and has the potential to reverse liver disease and prevent hospitalizations.

Contact Stimuliver
Visit Website